glp-1 news today october 23 2025 Compound versions of drugs for weight loss halted by FDA GLP-1 RA prescription trends: January

In many cases, side effects are manageableor subside as you adjust

Unfortunately, people with type 2 diabetes, make less than half of the usual amount of the GLP-1 and GIP hormones, which contributes to chronically elevated glucose levels

Zeng H, Song J, Li Y, Guo C, Zhang Y, Yin T, et al

GLP-1 agonists: act on the metabolism upstream by extrahepatic path The emergence of glucagon-like peptide-1 (GLP-1) agonists as a treatment option for diabetes and obesity has prompted their examination in patients with MASH 5

Dual-pathway agents like tirzepatide, which activate both GLP-1 and GIP receptors, demonstrate superior outcomesup to 20% weight losscompared to semaglutide alone

They will assess how long symptoms persisted, whether you maintained hydration, and your current clinical status